Applications to the FY23 JWMRP MMRDA are being solicited by the U.S. Army Medical Research Acquisition Activity (USAMRAA) using delegated authority provided by 10 USC 4001. The execution management agent for this BAA is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).
The MMRDA mechanism is intended to fund the logical continuation of previously funded, prior year research or development efforts relevant to the above FY23 JWMRP Focus Areas with the highest potential to augment and accelerate medical product development and health care solutions for military Service Members, Veterans, their families, other MHS beneficiaries, and/or the American public. The USAMRDC will implement this research program through the awarding of assistance agreements (grants and cooperative agreements), research contracts, or Other Transaction Agreements (OTAs). All invited applicants must submit full applications in accordance with the procedures outlined in this funding opportunity announcement. Collaboration with DOD organizations is encouraged when this alliance would contribute to the success of the research effort, and any funds designated for DOD laboratories or activities should be identified in the application through submission of a “Suggested Collaborating DOD Military Facility Budget Format,” Attachment 15.
The MMRDA mechanism supports a wide range of research projects, spanning late-stage preclinical studies, late-state technology development efforts, technology demonstration, and translational research.
Deadlines:
• Required Pre-Application Deadline: June 15, 2023
• Invitation to Submit an Application: July 2023
• Application Submission Deadline: September 7, 2023